Sarepta Updates UK Dosing in ENVISION Study of ELEVIDYS
May 21, 2025
Sarepta Therapeutics, the leader in precision genetic medicine for rare diseases, shared the following update related to ELEVIDYS, the only approved gene therapy for patients